Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

NCT03965052 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: PRO 179
DRUG: Travatan 0.004 % Ophthalmic Solution

Sponsor

Laboratorios Sophia S.A de C.V.